<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03300310</url>
  </required_header>
  <id_info>
    <org_study_id>RC17_0096</org_study_id>
    <secondary_id>2017-A00629-44</secondary_id>
    <nct_id>NCT03300310</nct_id>
  </id_info>
  <brief_title>Impact of the Nurse Visit on Observance of the Intake of Oral Carcinological Treatment in the Elderly</brief_title>
  <acronym>IPIO-PA</acronym>
  <official_title>Impact of the Nurse Visit on Observance of the Intake of Oral Carcinological Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The increasingly used oral anticancer treatments allow the patient to reduce treatment and
      social constraints to reduce hospitalization costs. The counterpart is a decrease in the
      monitoring of the correct intake of drugs and the detection of side effects. These two risks
      are major in the elderly, due to comorbidities, poly-medication and decreased attention. The
      project objective to evaluate the impact of a bi-weekly nursing visit to the patients' homes
      for 3 months, compared to a conventional management without a nursing visit. It is a
      prospective, randomized, controlled, multicenter study to include 224 patients over 18
      months. The impact will be assessed by counting the tablets not taken and by filling an
      observation booklet with the nurse at home.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2017</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison, at 3 months after the oncological treatments began, of the observance rate of the anticancer drugs (corresponding to the entire carcinological protocol) with or without passage of a nurse at the patient's home.</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of the patient's perception of observance to anticancer therapy</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of causes of possible premature and definitive cessation of cancer treatments 3 months after the start of treatment and changes in treatment (dose, rhythm of cycles)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of patients' satisfaction (of the arm with passage of the nurse) and the professionals</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of the percentage of patients able to be included in the study compared to the number of patients who received an oncogeriatric assessment</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">224</enrollment>
  <condition>Oncology, Gerontology</condition>
  <arm_group>
    <arm_group_label>with nursing visit</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a nurse visit is scheduled twice a week during 3 months at patient home.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without nursing visit</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>no nursing visit</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>nursing visit</intervention_name>
    <description>nursing visit at patient home</description>
    <arm_group_label>with nursing visit</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no nursing visit</intervention_name>
    <description>the patient take his treatment without nursing visit</description>
    <arm_group_label>without nursing visit</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient aged 70 and over

          -  Patient initiating an oral anticancer treatment (Chemotherapy, Targeted therapy, 2nd
             generation hormone therapy type Acetate abiraterone and Enzalutamide)

          -  Patient who received an onco-geriatric assessment

          -  Patient with informed consent signed

        Exclusion Criteria:

          -  Patient in a medical institution

          -  Patient under exclusive hormone therapy

          -  Patient already eligible for nurse support

          -  Patient not speaking French

          -  Patient under tutelage and guardianship or under safeguard of justice

          -  Patient already included in a research protocol

          -  Patient sharing his or her home with a person receiving nursing care at home more than
             once a week and for a period longer than 1 month after the patient's inclusion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laure De Decker, Pr</last_name>
    <phone>+33 2 40 16 50 54</phone>
    <email>Laure.dedecker@chu-nantes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>ICO Angers</name>
      <address>
        <city>Angers</city>
        <zip>49000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benedicte DAillieres, Dr</last_name>
      <email>Benedicte.DAillieres@ico.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHD Vendée</name>
      <address>
        <city>La Roche-sur-Yon</city>
        <zip>85000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Martine Martin-Grellier, Dr</last_name>
      <email>martine.martin@chd-vendee.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laure De Decker, Pr</last_name>
      <email>Laure.dedecker@chu-nantes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital privé du Confluent</name>
      <address>
        <city>Nantes</city>
        <zip>44200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Aude Bezier, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Saint Nazaire</name>
      <address>
        <city>Saint Nazaire</city>
        <zip>44 606</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne Lebatard-Sartre, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ICO Nantes</name>
      <address>
        <city>St Herblain</city>
        <zip>44805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emmanuelle Bourbouloux, Dr</last_name>
      <email>Emmanuelle.bourbouloux@ico.unicancer.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 27, 2017</study_first_submitted>
  <study_first_submitted_qc>October 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 3, 2017</study_first_posted>
  <last_update_submitted>December 5, 2017</last_update_submitted>
  <last_update_submitted_qc>December 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

